Predicting outcomes in malignant ovarian germ cell tumors using the modified International Germ Cell Cancer Collaborative Group classification system

被引:0
|
作者
Zhang, Xinyue [1 ,2 ]
Yang, Jie [1 ,2 ]
Xiang, Yang [1 ]
Wu, Ming [1 ]
Cao, Dongyan [1 ]
Wang, Jinhui [1 ]
Yang, Jiaxin [1 ,2 ]
机构
[1] Peking Union Med Coll Hosp, Obstet & Gynecol, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Beijing, Peoples R China
基金
国家重点研发计划;
关键词
Ovarian Neoplasms; Ovarian Diseases; PROGNOSTIC-FACTORS; CHEMOTHERAPY; MANAGEMENT; SURVIVAL; COHORT;
D O I
10.1136/ijgc-2024-005489
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives The aim of our study was to evaluate the feasibility of the modified International Germ Cell Cancer Collaborative Group risk classification system in Chinese female patients with malignant ovarian germ cell tumors and to identify predictive factors to enhance the risk classification system. Methods In this retrospective cohort analysis, patients with malignant ovarian germ cell tumors who received surgery with/without chemotherapy were included. These patients had been followed-up by Peking Union Medical College Hospital between 2011 to 2020. Patients without complete medical records or no follow-up information were excluded. Results The study enrolled a total of 271 patients. The risk model classified 106 (39.1%) patients as good-, 84 (31%) as intermediate-, and 81 (29.9%) as poor-risk. With a median follow-up time of 34 months (range 2-147), 48 (17.7%) recurrence and 16 (5.9%) deaths were observed. The risk classification significantly correlated with 3 year disease-free survival and overall survival (log rank p<0.001 and p=0.003, respectively). The survival outcomes of disease-free survival and overall survival were not statistically different among risk groups in patients who received neoadjuvant chemotherapy (log rank p=0.77 and 0.41, respectively). Univariate and multivariable analysis showed that tumor stage (p=0.033, hazard ratio (HR) 2.05, 95% confidence interval (CI) 1.06 to 3.96) was significantly associated with relapse or progression of disease. Patients over age 40 years exhibited a poor prognosis. Conclusion The modified International Germ Cell Cancer Collaborative Group risk classification system was efficacious in patients with malignant ovarian germ cell tumors and was significantly associated with disease-free survival and overall survival. Risk assessment after neoadjuvant chemotherapy may be more predictive than stratification at initial diagnosis. Age and tumor stage were definitive prognostic factors for germ cell tumors, which may need to be incorporated in the stratification system.
引用
收藏
页码:1745 / 1752
页数:8
相关论文
共 50 条
  • [21] Treatment of recurrent and persistent malignant ovarian germ cell tumors
    王含必
    杨佳欣
    沈铿
    郎景和
    生殖医学杂志, 2009, 18(S2) (S2) : 64 - 68
  • [22] Clinicopathological Characteristics and Treatment Outcomes of Pregnancy Complicated by Malignant Ovarian Germ Cell Tumors
    Zong, Xuan
    Yang, Jia-Xin
    Zhang, Ying
    Cao, Dong-Yan
    Shen, Keng
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 1347 - 1354
  • [23] Malignant ovarian germ cell tumors:: Analysis of 32 cases
    Yilmaz, F
    Gül, T
    Uzunlar, AK
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (06) : 569 - 573
  • [24] Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017
    Park, Meerim
    Lim, Jiwon
    Lee, Jun Ah
    Park, Hyeon Jin
    Park, Byung Kiu
    Lim, Myong Cheol
    Park, Sang-Yoon
    Won, Young-Joo
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 79 - 84
  • [25] Mediastinal germ cell tumors: Anatomopathology, classification, teratomas and malignant tumors
    Chetaille, B.
    Massard, G.
    Falcoz, P. -E.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2010, 66 (01) : 63 - 70
  • [26] Ovarian Germ Cell Tumors: Pictorial Essay
    Gica, Nicolae
    Peltecu, Gheorghe
    Chirculescu, Raluca
    Gica, Corina
    Stoicea, Mihai Ciprian
    Serbanica, Andreea Nicoleta
    Panaitescu, Anca Maria
    DIAGNOSTICS, 2022, 12 (09)
  • [27] Ovarian Stromal and Germ Cell Tumors
    Koulouris, Carolyn R.
    Penson, Richard T.
    SEMINARS IN ONCOLOGY, 2009, 36 (02) : 126 - 136
  • [28] Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors A MITO-9 Retrospective Study
    Mangili, Giorgia
    Sigismondi, Cristina
    Gadducci, Angiolo
    Cormio, Gennaro
    Scollo, Paolo
    Tateo, Saverio
    Ferrandina, Gabriella
    Greggi, Stefano
    Candiani, Massimo
    Lorusso, Domenica
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (08) : 1414 - 1421
  • [29] Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution
    Hu, Ting
    Fang, Yong
    Sun, Qian
    Zhao, Haiyue
    Ma, Ding
    Zhu, Tao
    Wang, Changyu
    SURGICAL ONCOLOGY-OXFORD, 2019, 31 : 8 - 13
  • [30] Childhood malignant ovarian germ cell tumors: a single institution experience
    Yang, C.
    Tan, J.
    Li, C. C.
    Zhang, J.
    Kong, X. R.
    Zhao, Z.
    Deng, X.
    Peng, L.
    Wang, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (05) : 700 - 703